Abstract

STUDY DESIGN: A Randomised control trial
PURPOSE: The study was done to compare the efficacy and safety of olopatadine and azelastine eyedrops in the treatment of allergic conjunctivitis.
METHOD: After fulfilling inclusion and exclusion criteria, 50 patients were recruited in the study and randomly categorised into two groups. One group consists of 25 patients using olopatadine eyedrops and other group consists of 25 patients using azelastine eyedrops. The symptom scores, sign scores, adverse effects, responder rates are compared on subsequent follow-ups for both the groups for 15 days period.
RESULT: Responder rates are more in olopatadine(92%) as compared to azelastine(80%) group. Adverse effects are more in azelastine(28%) than olopatadine(20%) group.
CONCLUSION: The symptom and sign scores in both the groups are reduced but more reduced in olopatadine group than azelastine group.

Full Text